Skip to main content
Be The Investor
S&P 500
7,580.07-1.82%
After Hours7,443.21-1.81%
Nasdaq Composite
25,437.00-2.86%
After Hours24,562.34-3.44%
Dow Jones
51,770.31-1.09%
After Hours51,184.70-1.13%
Russell 2000
2,811.84-1.66%
After Hours2,766.73-1.60%
VIX
VIX
19.42+12.91%
Bitcoin
77,493.13+0.38%
Ethereum
2,248.73+0.34%
Solana
95.82-0.41%
Gold
3,898.90-3.29%
Silver
49.28-5.93%
Copper
6.482-1.83%
WTI Crude Oil
104.12+2.08%
US 10-Year Treasury Yield
4.929-1.22%
Home›Stocks›VSXY
OverviewChartNewsFinancialsBusiness ModelCompetitorsStatisticsAnalysisEarningsValuationHoldersOptionsInsidersForecastCompareFAQ

Victoria's Secret & Company

VSXY
NYSEUnited States flagUSReal-Time Price
$96.62USD
-2.52 (-2.54%)Today
BTI Score

BASIC required or higher

View pricing
BTI Fair Market Cap
$5.38B
+43.29% vs fair
Consumer Cyclical
Hold

Victoria's Secret & Company (VSXY) Stock News

The latest Victoria's Secret & Company (VSXY) news in one feed: earnings updates, analyst ratings, product launches and regulatory filings, curated and summarized by BTI.

Victoria's Secret Uses Its Fashion Show to Test Brand Momentum

Victoria's Secret returned its fashion show to Los Angeles with Kylie Jenner and a broad performer lineup. The event can lift attention, but sales conversion will determine whether the turnaround lasts.

Three Premarket Moves, Three Very Different Catalysts

AstraZeneca rose on an Oracle AI collaboration, Versant gained after a target increase, and EyePoint fell after an analyst downgrade tied to a failed Phase 3 endpoint. The signals should not be conflated.